Presentation is loading. Please wait.

Presentation is loading. Please wait.

Ibrutinib, a Bruton’s tyrosine kinase inhibitor used for treatment of lymphoproliferative disorders, eliminates both aeroallergen skin test and basophil.

Published byAngélique Dumas Modified over 5 years ago

Similar presentations

Presentation on theme: "Ibrutinib, a Bruton’s tyrosine kinase inhibitor used for treatment of lymphoproliferative disorders, eliminates both aeroallergen skin test and basophil."— Presentation transcript:

1 Ibrutinib, a Bruton’s tyrosine kinase inhibitor used for treatment of lymphoproliferative disorders, eliminates both aeroallergen skin test and basophil activation test reactivity  Jennifer A. Regan, MD, PhD, Yun Cao, MD, Melanie C. Dispenza, MD, PhD, Shuo Ma, MD, PhD, Leo I. Gordon, MD, Adam M. Petrich, MD, Bruce S. Bochner, MD  Journal of Allergy and Clinical Immunology  Volume 140, Issue 3, Pages e1 (September 2017) DOI: /j.jaci Copyright © 2017 American Academy of Allergy, Asthma & Immunology Terms and Conditions

2 Fig 1 Ibrutinib inhibits basophil and mast cell activation in 2 subjects prescribed ibrutinib for CLL treatment. A, Demographic characteristics, BTK inhibitor clinical indication, ibrutinib dose, and IgE levels are listed for each subject. B, Skin test responses to cat allergen (subject 1) and ragweed (subject 2) before and during ibrutinib treatment (420 mg daily) in 2 patients being treated for CLL. C, Basophil activation responses to anti-IgE (72% and 89% positive, respectively, before starting ibrutinib) or fMLP (12% and 16% positive, respectively, before starting ibrutinib) are shown for these same 2 subjects. Journal of Allergy and Clinical Immunology  , e1DOI: ( /j.jaci ) Copyright © 2017 American Academy of Allergy, Asthma & Immunology Terms and Conditions

3 Fig 1 Ibrutinib inhibits basophil and mast cell activation in 2 subjects prescribed ibrutinib for CLL treatment. A, Demographic characteristics, BTK inhibitor clinical indication, ibrutinib dose, and IgE levels are listed for each subject. B, Skin test responses to cat allergen (subject 1) and ragweed (subject 2) before and during ibrutinib treatment (420 mg daily) in 2 patients being treated for CLL. C, Basophil activation responses to anti-IgE (72% and 89% positive, respectively, before starting ibrutinib) or fMLP (12% and 16% positive, respectively, before starting ibrutinib) are shown for these same 2 subjects. Journal of Allergy and Clinical Immunology  , e1DOI: ( /j.jaci ) Copyright © 2017 American Academy of Allergy, Asthma & Immunology Terms and Conditions

4 Fig 2 Ibrutinib and acalabrutinib inhibit basophil activation in vitro as measured by the BAT in whole blood samples obtained from healthy volunteers. Whole blood samples were obtained from healthy volunteers and preincubated with the indicated concentrations of the drug for 30 minutes; then, BAT was performed with the addition of anti-IgE or fMLP. Levels of anti-IgE and fMLP BAT from which the values were normalized averaged 62% ± 9% and 26% ± 1% positive. Values represent mean ± SEM (N = 3-4). Journal of Allergy and Clinical Immunology  , e1DOI: ( /j.jaci ) Copyright © 2017 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Download ppt "Ibrutinib, a Bruton’s tyrosine kinase inhibitor used for treatment of lymphoproliferative disorders, eliminates both aeroallergen skin test and basophil."

Similar presentations

A bioinformatics approach to identify patients with symptomatic peanut allergy using peptide microarray immunoassay Jing Lin, PhD, Francesca M. Bruni,

A bioinformatics approach to identify patients with symptomatic peanut allergy using peptide microarray immunoassay Jing Lin, PhD, Francesca M. Bruni,
Repeated low-dose intradermal allergen injection suppresses allergen-induced cutaneous late responses  Giuseppina Rotiroti, MD, Mohamed Shamji, PhD, Stephen.

Repeated low-dose intradermal allergen injection suppresses allergen-induced cutaneous late responses  Giuseppina Rotiroti, MD, Mohamed Shamji, PhD, Stephen.
The use of serum-specific IgE measurements for the diagnosis of peanut, tree nut, and seed allergy  Jennifer M. Maloney, MD, Magnus Rudengren, BSc, Staffan.

The use of serum-specific IgE measurements for the diagnosis of peanut, tree nut, and seed allergy  Jennifer M. Maloney, MD, Magnus Rudengren, BSc, Staffan.
Wen Chin Chiang, MRCPCH, Chiung-Hui Huang, PhD, Genevieve V

Wen Chin Chiang, MRCPCH, Chiung-Hui Huang, PhD, Genevieve V
Allergen immunotherapy: A practice parameter third update

Allergen immunotherapy: A practice parameter third update
Early suppression of basophil activation during allergen-specific immunotherapy by histamine receptor 2  Natalija Novak, MD, Nihal Mete, MD, Caroline.

Early suppression of basophil activation during allergen-specific immunotherapy by histamine receptor 2  Natalija Novak, MD, Nihal Mete, MD, Caroline.
Clarification concerning amoxicillin skin testing

Clarification concerning amoxicillin skin testing
Alexandra Kazaks, MA, RD, Janet Y. Uriu-Adams, PhD, Judith S

Alexandra Kazaks, MA, RD, Janet Y. Uriu-Adams, PhD, Judith S
Margaretha A. Faber, MD, Vito Sabato, MD, Chris H

Margaretha A. Faber, MD, Vito Sabato, MD, Chris H
Kyoung-Bok Min, MD, PhD, Jin-Young Min, PhD 

Kyoung-Bok Min, MD, PhD, Jin-Young Min, PhD 
Delayed clinical and ex vivo response to mammalian meat in patients with IgE to galactose-alpha-1,3-galactose  Scott P. Commins, MD, PhD, Hayley R. James,

Delayed clinical and ex vivo response to mammalian meat in patients with IgE to galactose-alpha-1,3-galactose  Scott P. Commins, MD, PhD, Hayley R. James,
Advances in food allergy in 2015

Advances in food allergy in 2015
Role of the basophil activation test in the diagnosis of local allergic rhinitis  Enrique Gómez, PhD, Paloma Campo, MD, PhD, Carmen Rondón, MD, PhD, Esther.

Role of the basophil activation test in the diagnosis of local allergic rhinitis  Enrique Gómez, PhD, Paloma Campo, MD, PhD, Carmen Rondón, MD, PhD, Esther.
Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 

Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 
Giant ragweed specific immunotherapy is not effective in a proportion of patients sensitized to short ragweed: Analysis of the allergenic differences.

Giant ragweed specific immunotherapy is not effective in a proportion of patients sensitized to short ragweed: Analysis of the allergenic differences.
Making the Most of In Vitro Tests to Diagnose Food Allergy

Making the Most of In Vitro Tests to Diagnose Food Allergy
Bruton tyrosine kinase mediates TLR9-dependent human dendritic cell activation  Vassilios Lougaris, MD, Manuela Baronio, PhD, Massimiliano Vitali, PhD,

Bruton tyrosine kinase mediates TLR9-dependent human dendritic cell activation  Vassilios Lougaris, MD, Manuela Baronio, PhD, Massimiliano Vitali, PhD,
Stephen J. Fowler, MD, Gaël Tavernier, PhD, Robert Niven, MD 

Stephen J. Fowler, MD, Gaël Tavernier, PhD, Robert Niven, MD 
Dorothy M. Ryan, MD, Stephen J. Fowler, MD, Robert M. Niven, MD 

Dorothy M. Ryan, MD, Stephen J. Fowler, MD, Robert M. Niven, MD 
Is 9 more than 2 also in allergic airway inflammation?

Is 9 more than 2 also in allergic airway inflammation?

Similar presentations

Ads by Google